COCOS trial: COrticosteroids for COVID-19-induced loss of Smell–protocol for a single-centred, double-blind, randomised, placebo-controlled trial

INTRODUCTION: Hyposmia and anosmia are common in COVID-19. Most patients regain normal smell within 4 weeks, but severe loss of smell persists roughly in 20% after 2 months and may last up to a year or longer. These persistent smell disorders greatly influence daily life. It is hypothesised that COV...

Descripción completa

Detalles Bibliográficos
Autores principales: Schepens, Emma J A, Boek, Wilbert M, Boesveldt, Sanne, Stegeman, Inge, Stokroos, Robert J, Kamalski, Digna M A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Ear, Nose and Throat/Otolaryngology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9378948/
https://www.ncbi.nlm.nih.gov/pubmed/35948382
http://dx.doi.org/10.1136/bmjopen-2021-060416

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9378948/
https://www.ncbi.nlm.nih.gov/pubmed/35948382
http://dx.doi.org/10.1136/bmjopen-2021-060416

Ejemplares similares